Surmodics, Inc. operates in the Patent owners and lessors sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Surmodics with three other
financial institutions in North America:
Gladstone Investment Corporation
sales of $67.26 million
of which 100%
was Diversified Investment),
Tekla Healthcare Investors
Eaton Vance Enhanced Equity Income Fund
Surmodics reported sales of $73.11 million
September of 2017.
increase of 2.4%
versus 2016, when the company's sales were $71.37 million.
Sales at Surmodics have increased during each of the previous five years
(and since 2012, sales have increased a total of 41%).
Sales of Diagnostics/in Vitro saw an increase
that was more than double the company's growth rate: sales were up
5.3% in 2017, from
$18.16 million to $19.13 million.